[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
August 15, 2001

Safety Alerts Involving Device Therapy for Arrhythmias

Author Affiliations

Author Affiliations: Division of Cardiovascular Disease, University of Michigan Medical Center, Ann Arbor.

JAMA. 2001;286(7):843-844. doi:10.1001/jama.286.7.843

Technological developments in device therapy for both bradyarrhythmias and tachyarrhythmias have benefited hundreds of thousands of patients over the past several decades. By the end of 2000, more than 900 000 persons in the United States had a pacemaker or implantable cardioverter-defibrillator (ICD) generator.1 The benefits of modern-day pacing and defibrillator therapy on both quality and quantity of life are well documented.24 Moreover, the recent receipt of an ICD by Vice President Richard Cheney has resulted in increased public awareness about the use and capabilities of these devices.

First Page Preview View Large
First page PDF preview
First page PDF preview
×